Association of Elevated Lipoprotein A With Adverse Cardiovascular Events Following Percutaneous Coronary Intervention

被引：0
|
作者：
Oliver, Walter
Besser, Stephanie A.
Berman, Adam N.
Biery, David W.
Shiyovich, Arthur
Abdelrahman, Khaled
Hainer, Jon
Laychak, Shelby
Huck, Daniel M.
Weber, Brittany N.
Di Carli, Marcelo F.
Cannon, Christopher P.
Bhatt, Deepak L.
Blankstein, Ron
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Lipoproteins; Percutaneous coronary intervention (PCI); Risk Factors; Coronary heart disease; Lipids;
D O I：
10.1161/circ.148.suppl_1.16718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16718
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [2] Association of depression with adverse cardiovascular events after percutaneous coronary intervention
    Wang, Zhi Jian
    Guo, Min
    Si, Tian Mei
    Jiang, Ming Ming
    Liu, Si Meng
    Liu, Yu Yang
    Zhao, Ying Xin
    Shi, Dong Mei
    Zhou, Yu Jie
    [J]. CORONARY ARTERY DISEASE, 2013, 24 (07) : 589 - 595
  • [3] Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention
    Yoon, Yong-Hoon
    Ahn, Jung-Min
    Kang, Do-Yoon
    Lee, Pil Hyung
    Kang, Soo-Jin
    Park, Duk-Woo
    Lee, Seung-Whan
    Kim, Young-Hak
    Han, Ki Hoon
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (18) : 2059 - 2068
  • [4] Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
    Sud, Maneesh
    Han, Lu
    Koh, Maria
    Abdel-Qadir, Husam
    Austin, Peter C.
    Farkouh, Michael E.
    Godoy, Lucas C.
    Lawler, Patrick R.
    Udell, Jacob A.
    Wijeysundera, Harindra C.
    Ko, Dennis T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (12) : 1440 - 1450
  • [5] Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
    Mahmud, Ehtisham
    Behnamfar, Omid
    Lin, Felice
    Reeves, Ryan
    Patel, Mitul
    Ang, Lawrence
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (21) : 2556 - 2557
  • [6] The Toronto risk score for major adverse cardiovascular events following percutaneous coronary intervention
    Ivanov, Joan
    Chowdhary, Saqib
    Horlick, Eric
    Seidelin, Peter
    Mackie, Karen
    Dzavik, Vlad
    [J]. CIRCULATION, 2006, 114 (18) : 842 - 842
  • [7] ASSOCIATION OF LIPOPROTEIN (A) WITH CLINICAL EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION
    Ezhov, M.
    Matchin, Y.
    Afanasieva, O.
    Docenko, Y.
    Afanasieva, M.
    Lyakishev, A.
    Pokrovsky, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [8] Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
    Ang, Lawrence
    Behnamfar, Omid
    Palakodeti, Samhita
    Lin, Felice
    Pourdjabbar, Ali
    Patel, Mitul P.
    Reeves, Ryan R.
    Mahmud, Ehtisham
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
  • [9] Association between late sleeping and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Lian, Xiao-Qing
    Jiang, Kun
    Chen, Xiang-Xuan
    Dong, Hai-Cui
    Zhang, Yu-Qing
    Wang, Lian-Sheng
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [10] Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Xiao, Zhibin
    Riletu, Aoge
    Yan, Xiaoyu
    Meng, Qi
    Zhang, Weiru
    Zhang, Na
    Ma, Chi
    Guo, Xin
    Han, Jiatong
    Nie, Huijuan
    Deng, Hui
    Liu, Jing
    Chen, Jianping
    Dong, Yu
    Liu, Tianlong
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04) : 621 - 629
12345